Two Sigma Securities’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Two Sigma Securities's CDLX Position: Q1 2026 in Review
Two Sigma Securities reduced its Cardlytics (CDLX) stake by 13% in Q1 2026, selling an estimated $4.81K and leaving 3,162 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.
Two Sigma Securities first reported a position in CDLX in Q4 2019 and has held it in 4 quarters since. The position peaked at $205K in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Two Sigma Securities held 3,162 shares of Cardlytics worth $33.2K as of Q1 2026.
- Two Sigma Securities sold 493 Cardlytics shares in Q1 2026, an estimated $4.81K.
- Cardlytics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1311 holding.
- Two Sigma Securities first reported a position in Cardlytics in Q4 2019 and has held it in 4 quarters since.
- Two Sigma Securities's Cardlytics position peaked at $205K in Q4 2019.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.